GenScript Biotech Corporation, specialists in synthetic biology and gene synthesis services, has announced the launch of its newest offering, the GenScript FLASH Gene service. This ultra-fast sequence-to-plasmid (S2P) service aims to meet the growing demand for rapid delivery of gene
Thermo Fisher Scientific has expanded its clinical research capabilities with the unveiling of a new 72,500-square-foot laboratory building at its good manufacturing practices (GMP) site in Middleton, Wisconsin. This addition enhances the company’s chemistry, manufacturing, and control (CMC) analytical services,
Siegfried, a global contract development and manufacturing organization (CDMO) headquartered in Zofingen, Switzerland, has signed agreements with Curia Global for the acquisition of an early-phase CDMO site in Grafton, WI. The transaction is expected to close by July 1, 2024.
MilliporeSigma has announced a €62 million investment in a new quality control building at its Darmstadt headquarters. Scheduled for completion by mid-2025, the nearly 10,000 square meter facility will consolidate approximately 135 employees from various departments into a collaborative, state-of-the-art
Almac Pharma Services, part of the Almac Group, has successfully supported the commercial packaging and rapid launch of BioLineRx’s APHEXDA® (motixafortide) into the US market. The treatment, approved by the FDA on 11 September 2023, is used to mobilise hematopoietic
In the rapidly evolving biopharmaceutical landscape, biologics or ‘large molecule’ therapies have emerged as a crucial segment, promising innovative treatments for a wide-range of diseases. 90% of biotechs choose to partner with a Contract Development and Manufacturing Organisation (CDMO) to
EUROAPI has announced a five-year development and manufacturing agreement with Priothera, a biotechnology company focused on treatments for hematological malignancies and CAR-T cell therapies. This collaboration aims to develop and industrialize the manufacturing process of mocravimod, an innovative oncology molecule,
Lupin has announced the formation of a new subsidiary, Lupin Manufacturing Solutions (LMS), marking its entry into the contract development and manufacturing organisation (CDMO) sector. On Monday, the company named Abdelaziz Toumi (Abdel) as the chief executive officer of LMS.
Charles River Laboratories International Inc. and Captain T Cell, a spinoff from the Max Delbrück Center Berlin, Germany, have signed an agreement to produce plasmid DNA and retrovirus vectors. This collaboration is part of Charles River’s Cell and Gene Therapy
Actylis, a global manufacturer and sourcing expert of critical materials and performance ingredients for the life sciences and specialty chemicals markets, has appointed Scott Thomson as Chief Executive Officer. Thomson, who has a thirty-year track record in the pharmaceutical and
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
